Eurofins Listed by nova Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

People who have dealt with laboratories, food producers, pharmaceutical firms or environmental services may have personal or professional details sitting inside systems belonging to a major testing network. When a ransomware group publicly lists that network as a victim, the practical question is simple: has any of that information left the organisation’s control, and what should individuals do next?

On 6 July 2025 Eurofins was named on the leak site of the ransomware group known as nova. Public reporting states that internal files were exfiltrated during a ransomware attack. The number of people affected remains unknown, and the precise contents of the files have not been detailed beyond that description. The listing itself is a claim by the group; independent confirmation of the full scope has not been published.

What happened

According to the available record, Eurofins was listed by the nova ransomware group on 6 July 2025. The report characterises the incident as a ransomware attack in which internal files were taken. No further public detail has been released about the date the intrusion began, the method of initial access, the volume of data removed, or whether systems were encrypted. The number of individuals whose information may be involved is listed as unknown. Because the only source for the listing is the group’s own site, the claim should be treated as unverified until Eurofins or independent investigators provide confirmation.

Who is nova?

Nova is a ransomware operation that has appeared in public reporting in recent years. Like many contemporary groups it follows a double-extortion model: data is copied out of the victim’s network and systems are often encrypted, after which the group demands payment and threatens to publish the stolen material if the demand is not met. Victims are typically named on a dedicated leak site. The group has been observed targeting organisations across multiple sectors rather than specialising in one industry. Public analyses describe its tooling and negotiation style as consistent with other mid-tier ransomware crews that rely on initial access brokers and living-off-the-land techniques. No specific statements by nova about Eurofins beyond the act of listing the organisation have been recorded in the available facts; any additional claims that may appear on the leak site remain unconfirmed.

Eurofins and its sector

Eurofins Scientific operates as a global network of life-sciences companies. It provides analytical testing services to clients in food, environmental, pharmaceutical, cosmetic and related industries. Laboratories of this type routinely handle samples, test results, client contracts, employee records and, in some cases, personal data linked to clinical or consumer studies. Because the organisation sits at the centre of supply-chain quality control and regulatory compliance for many manufacturers, a compromise can affect not only Eurofins itself but also the companies and individuals whose materials or information pass through its facilities. The sector is attractive to ransomware operators precisely because downtime and data exposure create immediate commercial and regulatory pressure.

What was likely exposed

The only data type named in the public record is “internal files exfiltrated in a ransomware attack.” No inventory of those files has been released. Organisations that perform laboratory testing commonly hold client lists, contracts, laboratory information-management system records, employee directories, financial documents and, depending on the service line, limited personal data associated with samples or studies. Whether any of those categories were among the files allegedly taken from Eurofins has not been confirmed. Until a detailed disclosure appears, the exact contents remain unconfirmed and should not be assumed.

Why it matters

For individuals, the main risks are secondary misuse of any personal or contact information that may have been present in the internal files—phishing, social-engineering attempts, or identity-related fraud. For client companies the exposure of contracts, test data or proprietary formulations could create competitive or compliance problems. For Eurofins itself the incident raises operational, reputational and regulatory questions, particularly if personal data of European residents falls under GDPR or similar regimes. Because the scale is unknown, the practical impact cannot yet be measured; the listing alone is enough to warrant caution among anyone who has interacted with the organisation’s laboratories or corporate systems.

If your data was in this claimed breach

Monitor financial and email accounts for unexpected activity. Treat unsolicited messages that reference laboratory work, invoices or personal details with extra scrutiny. Change passwords on any accounts that may have shared credentials with Eurofins-related services, and enable multi-factor authentication where it is available. Consider placing a fraud alert with credit-reporting agencies if you believe sensitive personal identifiers could have been involved. Readers can also run a free exposure scan of their email address to check whether that address has already appeared in other known breach data sets; such a scan does not confirm or rule out involvement in this specific incident, but it provides a practical starting point for personal risk assessment.

AICompiled with AI assistance from public sources and published under our editorial standards.